Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GIST.

about

Surgery and imatinib therapy for liver oligometastasis of GIST: a study of Japanese Study Group on GIST.

Item

http://www.wikidata.org/entity/Q50219275

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@en

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@nl

type

Item

label

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@en

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@nl

prefLabel

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@en

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@nl

P1476

Surgery and imatinib therapy f ...... Japanese Study Group on GIST.

@en

P2093

Akinori Takagane

http://www.w3.org/2001/XMLSchema#string

Harutsugu Sodeyama

http://www.w3.org/2001/XMLSchema#string

Hitoshi Ojima

http://www.w3.org/2001/XMLSchema#string

Izumi Mochizuki

http://www.w3.org/2001/XMLSchema#string

Osamu Ikawa

http://www.w3.org/2001/XMLSchema#string

Takashi Ishikawa

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kagimura

http://www.w3.org/2001/XMLSchema#string

Tatsuo Kanda

http://www.w3.org/2001/XMLSchema#string

Toru Masuzawa

http://www.w3.org/2001/XMLSchema#string

Toshihiro Hirai

http://www.w3.org/2001/XMLSchema#string

P2860

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver.

Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection.

Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors.

Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas.

Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy.

Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version.

Results of Hepatic Resection for Sarcoma Metastatic to Liver

P304

369-372

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYW203

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28073945

http://www.w3.org/2001/XMLSchema#string